Merck Operating Income from 2010 to 2026

MRK Stock   27.83  0.87  3.23%   
Merck Operating Income yearly trend continues to be very stable with very little volatility. Operating Income is likely to drop to about 17.5 B. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Merck Co generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
22.1 B
Current Value
17.5 B
Quarterly Volatility
3.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Tax Provision of 2.5 B, Interest Income of 352 M or Interest Expense of 1.3 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
This module can also supplement various Merck Technical models . Check out the analysis of Merck Correlation against competitors.
Evaluating Merck's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Merck Co's fundamental strength.

Latest Merck's Operating Income Growth Pattern

Below is the plot of the Operating Income of Merck Co over the last few years. Operating Income is the amount of profit realized from Merck operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Merck Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Merck's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merck's overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Pretty Stable
   Operating Income   
       Timeline  

Merck Operating Income Regression Statistics

Arithmetic Mean17,672,241,176
Geometric Mean16,662,527,631
Coefficient Of Variation22.26
Mean Deviation1,754,162,630
Median18,282,000,000
Standard Deviation3,934,306,440
Sample Variance15478767.2T
Range19.2B
R-Value(0.14)
Mean Square Error16184985.1T
R-Squared0.02
Significance0.59
Slope(109,426,961)
Total Sum of Squares247660274.6T

Merck Operating Income History

202617.5 B
202522.1 B
202420.2 B
2023B

About Merck Financial Statements

Merck investors utilize fundamental indicators, such as Operating Income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Income22.1 B17.5 B

Pair Trading with Merck

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Merck position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will appreciate offsetting losses from the drop in the long position's value.

Moving together with Merck Stock

  0.9JNJ Johnson Johnson CDRPairCorr
  1.0MRK Merck CDRPairCorr
  0.82AMGN Amgen CDRPairCorr

Moving against Merck Stock

  0.52VRY Petro Victory EnergyPairCorr
  0.37HWO High Arctic EnergyPairCorr
The ability to find closely correlated positions to Merck could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck Co to buy it.
The correlation of Merck is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Merck can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Merck Stock

Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.